Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Serum Soluble Urokinase Plasmi...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension

Serum Soluble Urokinase Plasminogen Activator Receptor Levels in Resistant Hypertension

Bibliographic Details
Main Authors: Nergiz Bayrakcı, Gülsüm Özkan, Sonat Pınar Kara, Ahsen Yılmaz, Aliye Çelikkol
Format: Article
Language:English
Published: AVES 2024-04-01
Series:Turkish Journal of Nephrology
Online Access:https://turkjnephrol.org/en/serum-soluble-urokinase-plasminogen-activator-receptor-levels-in-resistant-hypertension-137178
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

https://turkjnephrol.org/en/serum-soluble-urokinase-plasminogen-activator-receptor-levels-in-resistant-hypertension-137178

Similar Items

  • Serum Calprotectin Level as an Inflammatory Marker in Newly Diagnosed Hypertensive Patients
    by: Nergiz Bayrakci, et al.
    Published: (2022-01-01)
  • MicroRNA 21 and microRNA 155 levels in resistant hypertension, and their relationships with aldosterone
    by: Sonat Pınar Kara, et al.
    Published: (2021-01-01)
  • The Prognostic Significance of Soluble Urokinase Plasminogen Activator Receptor in Acute Myeloid Leukemia
    by: Nergiz Erkut, et al.
    Published: (2016-05-01)
  • The Relationship Between Serum Magnesium Level, Plasma Atherogenic Index and Glomerular Filtration Rate
    by: Nergiz BAYRAKCI, et al.
    Published: (2022-09-01)
  • Evaluation of Urokinase Plasminogen Activator Receptor, Soluble Urokinase Plasminogen Activator Receptor, and β1 Integrin in Patients with Hodgkin′s Lymphoma
    by: Shirin Kouhpayeh, et al.
    Published: (2017-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs